To counteract this, Fu et al. [103] developed a pH- and temperature-sensitive liposome loaded with a photothermal agent, an IDO1 inhibitor, and modified with interleukin-15 (IL-15) and tumor-specific targeting ligands. Here, IL15 is linked to neoplasm.